- Home
- EVOK vs SILO Comparison
EVOK vs SILO Comparison
Compare EVOK & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- SILO
- Stock Information
- Founded
- EVOK 2007
- SILO 2010
- Country
- EVOK United States
- SILO United States
- Employees
- EVOK N/A
- SILO N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- SILO Apparel
- Sector
- EVOK Health Care
- SILO Consumer Discretionary
- Exchange
- EVOK Nasdaq
- SILO Nasdaq
- Market Cap
- EVOK 5.4M
- SILO 4.5M
- IPO Year
- EVOK 2013
- SILO N/A
- Fundamental
- Price
- EVOK $5.12
- SILO $0.71
- Analyst Decision
- EVOK
- SILO
- Analyst Count
- EVOK 0
- SILO 0
- Target Price
- EVOK N/A
- SILO N/A
- AVG Volume (30 Days)
- EVOK 104.5K
- SILO 547.0K
- Earning Date
- EVOK 08-14-2025
- SILO 08-13-2025
- Dividend Yield
- EVOK N/A
- SILO N/A
- EPS Growth
- EVOK N/A
- SILO N/A
- EPS
- EVOK N/A
- SILO N/A
- Revenue
- EVOK $12,794,859.00
- SILO $72,102.00
- Revenue This Year
- EVOK $57.82
- SILO $1.86
- Revenue Next Year
- EVOK $59.12
- SILO N/A
- P/E Ratio
- EVOK N/A
- SILO N/A
- Revenue Growth
- EVOK 70.02
- SILO N/A
- 52 Week Low
- EVOK $1.94
- SILO $0.41
- 52 Week High
- EVOK $12.32
- SILO $3.37
- Technical
- Relative Strength Index (RSI)
- EVOK 55.77
- SILO 54.77
- Support Level
- EVOK $4.61
- SILO $0.56
- Resistance Level
- EVOK $5.70
- SILO $0.72
- Average True Range (ATR)
- EVOK 0.52
- SILO 0.07
- MACD
- EVOK -0.03
- SILO 0.00
- Stochastic Oscillator
- EVOK 71.01
- SILO 65.50
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.